| 序号 | 药品通用名称 | 英文名称/商品名 | 规格 | 剂型 | 持证商 | 备注1 | 备注2 | 信息来源 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3831 | 盐酸羟考酮缓释片 | Oxycodone Hydrochloride Prolonged-release Tablets/OXYCONTIN | 80mg | 片剂 | NAPP PHARMACEUTICALS LIMITED | 原研进口 | 第十三批 | ||||||||||
| 3832 | 盐酸羟考酮缓释片 | Oxycodone Hydrochloride Prolonged-release Tablets/OXYCONTIN | 60mg | 片剂 | NAPP PHARMACEUTICALS LIMITED | 原研进口 | 第十三批 | ||||||||||
| 3833 | 盐酸羟考酮缓释片 | Oxycodone Hydrochloride Prolonged-release Tablets/OXYCONTIN | 40mg | 片剂 | NAPP PHARMACEUTICALS LIMITED | 原研进口 | 第十三批 | ||||||||||
| 3834 | 盐酸羟考酮缓释片 | Oxycodone Hydrochloride Prolonged-release Tablets/OXYCONTIN | 30mg | 片剂 | NAPP PHARMACEUTICALS LIMITED | 原研进口 | 第十三批 | ||||||||||
| 3835 | 盐酸羟考酮缓释片 | Oxycodone Hydrochloride Prolonged-release Tablets/OXYCONTIN | 20mg | 片剂 | NAPP PHARMACEUTICALS LIMITED | 原研进口 | 第十三批 | ||||||||||
| 3836 | 盐酸羟考酮缓释片 | Oxycodone Hydrochloride Prolonged-release Tablets/OXYCONTIN | 15mg | 片剂 | NAPP PHARMACEUTICALS LIMITED | 原研进口 | 第十三批 | ||||||||||
| 3837 | 盐酸羟考酮缓释片 | Oxycodone Hydrochloride Prolonged-release Tablets/OXYCONTIN | 10mg | 片剂 | NAPP PHARMACEUTICALS LIMITED | 原研进口 | 第十三批 | ||||||||||
| 3838 | 盐酸羟考酮缓释片 | Oxycodone Hydrochloride Prolonged-release Tablets/OXYCONTIN | 5mg | 片剂 | NAPP PHARMACEUTICALS LIMITED | 原研进口 | 第十三批 | ||||||||||
| 3839 | 复方甘草酸苷片 | Compound Glycyrrhizin Tablets/Stronger Neo-Minophagen C(美能) | 甘草酸单铵盐35mg（甘草酸苷25mg）、甘氨酸25mg、DL-蛋氨酸25mg | 片剂 | Minophagen Pharmaceutical Co., Ltd. | 原研进口 | 第十三批 | ||||||||||
| 3840 | 瑞格列奈二甲双胍片 | Repaglinide and Metformin Hydrochloride Tablets/-- | 2mg/500mg | 片剂 | LUPIN LTD | 美国橙皮书 | 第十三批 | ||||||||||
© 2021 诸侯快讯手机版. ALL RIGHTS RESERVED
浙ICP备13034926号-1
(浙)-非经营性-2022-0016 浙公网安备 33010802005916号
© 2021 诸侯快讯手机版. ALL RIGHTS RESERVED浙ICP备13034926号-1 (浙)-非经营性-2022-0016 浙公网安备 33010802005916号
You are welcome to contact us via the online form below.
We will answer your inquiries in various ways, and jointly provide customized professional consultation and solutions for your research and development needs.
